Showing results (631-640 of 1,963) with videos related to

Sort By:
Pageof 197
RMD Open|February 5, 2019
Novel protective role for MAP kinase phosphatase 2 in inflammatory arthritisJuliane Schroeder, Kirsty Ross, Kathryn McIntosh, et al.
RMD Open|November 21, 2017
Patient-physician collaboration in rheumatology: a necessityElena Nikiphorou, Alessia Alunno, Loreto Carmona, et al.
RMD Open|January 21, 2020
Glucocorticoids in rheumatoid arthritis: current status and future studiesCharlotte Hua, Frank Buttgereit, Bernard Combe
RMD Open|January 21, 2020
Fatigue numeric rating scale validity, discrimination and responder definition in patients with psoriatic arthritisDafna Gladman, Peter Nash, Hitoshi Goto, et al.
RMD Open|January 21, 2020
Methotrexate effect on immunogenicity and long-term maintenance of adalimumab in axial spondyloarthritis: a multicentric randomised trialEmilie Ducourau, Theo Rispens, Marine Samain, et al.
RMD Open|January 21, 2020
Pooled analysis of TNF inhibitor biosimilar studies comparing radiographic progression by disease activity states in rheumatoid arthritisJosef S Smolen, Jung-Yoon Choe, Michael E Weinblatt, et al.
RMD Open|May 16, 2022
Antibody response to the COVID-19 ChAdOx1nCov-19 and BNT162b vaccines after temporary suspension of DMARD therapy in immune-mediated inflammatory disease (RESCUE)Ai Phuong Tran, Daniel Tassone, Johannes Nossent, et al.
RMD Open|June 2, 2022
Effect of tofacitinib on pain, fatigue, health-related quality of life and work productivity in patients with active ankylosing spondylitis: results from a phase III, randomised, double-blind, placebo-controlled trialVictoria Navarro-Compán, James Cheng-Chung Wei, Filip Van den Bosch, et al.
RMD Open|March 21, 2018
Identification of sarilumab pharmacodynamic and predictive markers in patients with inadequate response to TNF inhibition: a biomarker substudy of the phase 3 TARGET studyCem Gabay, Jérôme Msihid, Moshe Zilberstein, et al.
RMD Open|December 20, 2018
Sick leave and its predictors in ankylosing spondylitis: long-term results from the Outcome in Ankylosing Spondylitis International StudyCasper Webers, Sofia Ramiro, Robert Landewé, et al.
Pageof 197